Abstract: The present disclosure relates to a short-range communication device (10, 10?, 5 10?) for a personal protective equipment or a personal protective device (200, 210, 220, 230) comprising a transmission unit (20, 20?, 20?) for wirelessly transmitting a voice signal of a user (100, 110, 120, 130, 140, 150, 160) to a receiving unit (40,40?, 40?) over a predetermined distance such that a communication channel is established between the transmission unit (20, 20?, 20?) and the receiving unit (40, 40?, 40?) so that a user (100, 10 110, 120, 130, 140, 150, 160) can hear the voice signal. The present disclosure further relates to a short-range communication system comprising at least two short-range communication devices (10, 10?, 10?) according to the present disclosure and to a method of establishing a short-range communication between such devices (10, 10?, 10?).

Abstract: Methods and apparatus for evaluating collected data relating to online activity, and modification of services within a service provider network. In one embodiment, a service provider collects data relating to the online activity of users of third-party services and correlates the data with subscribers of the service provider to generate useful products and analytics (e.g., classifications, behavioral models, etc.) containing information relating to the subscribers' online activity. The generated products may be used to determine whether and how to modify services provided to individual subscribers, exported for use by third parties, or for other purposes.

Abstract: Methods and apparatus for evaluating collected data relating to online activity, and modification of services within a service provider network. In one embodiment, a service provider collects data relating to the online activity of users of third-party services and correlates the data with subscribers of the service provider to generate useful products and analytics (e.g., classifications, behavioral models, etc.) containing information relating to the subscribers' online activity. The generated products may be used to determine whether and how to modify services provided to individual subscribers, exported for use by third parties, or for other purposes.

Abstract: Methods and apparatus for evaluating collected data relating to online activity, and modification of services within a service provider network. In one embodiment, a service provider collects data relating to the online activity of users of third-party services and correlates the data with subscribers of the service provider to generate useful products and analytics (e.g., classifications, behavioral models, etc.) containing information relating to the subscribers' online activity. The generated products may be used to determine whether and how to modify services provided to individual subscribers, exported for use by third parties, or for other purposes.

Abstract: Methods and apparatus for evaluating collected data relating to online activity, and modification of services within a service provider network. In one embodiment, a service provider collects data relating to the online activity of users of third-party services and correlates the data with subscribers of the service provider to generate useful products and analytics (e.g., classifications, behavioral models, etc.) containing information relating to the subscribers' online activity. The generated products may be used to determine whether and how to modify services provided to individual subscribers, exported for use by third parties, or for other purposes.

Abstract: Methods and apparatus for evaluating collected data relating to online activity, and modification of services within a service provider network. In one embodiment, a service provider collects data relating to the online activity of users of third-party services and correlates the data with subscribers of the service provider to generate useful products and analytics (e.g., classifications, behavioral models, etc.) containing information relating to the subscribers' online activity. The generated products may be used to determine whether and how to modify services provided to individual subscribers, exported for use by third parties, or for other purposes.

Abstract: Methods and apparatus for evaluating collected data relating to online activity, and modification of services within a service provider network. In one embodiment, a service provider collects data relating to the online activity of users of third-party services and correlates the data with subscribers of the service provider to generate useful products and analytics (e.g., classifications, behavioral models, etc.) containing information relating to the subscribers' online activity. The generated products may be used to determine whether and how to modify services provided to individual subscribers, exported for use by third parties, or for other purposes.

Abstract: The present invention relates to a combination of a selective PDB4 inhibitor and an anticholinergic agent for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease, with the proviso that the anticholinergic agent is not a tiotropium salt.

Abstract: Stasis is treated or prevented in all or any part or parts of the stomach of a patient, especially a human patient, in need of such treatment, where said stasis results from hypomotility in the stomach, particularly gastric hypomotility with delayed emptying of the liquid and/or solid contents of the stomach. Gastric or gastrointestinal disorders are also treated which are characterized by one or more symptoms selected from pain, nausea, vomiting, heartburn, postprandial discomfort, indigestion and gastroesophageal reflux. Such treatment or prevention is achieved by administering to the patient a therapeutically effective amount of an inhibitor of phosphodiesterase-4 (PDE4), including isozyme subtypes thereof, sufficient to treat or prevent such hypomotility or gastric or gastrointestinal disorder in said patient.

Abstract: A method is described in accordance with which one may select a nonsedating histamine H1-antagonist; comprising the step of determining whether a candidate H1-antagonist is a substrate for P-gp, especially P-gp expressed by MDR1 or mdr1a/1b, comprising the step of determining the brain-to-plasma AUC ratio in mdr1a/1b KO mice, and in WT mice, and selecting said candidate where the brain-to-plasma AUC ratio for said KO mice to the brain-to-plasma concentration ratio for said WT mice is 1.5 or greater.

Abstract: A combination of therapeutic agents useful in the treatment of obstructive airways and other inflammatory diseases comprising (i) an adenosine A2A receptor agonist; and (ii) an anti-cholinergic agent, preferably comprising a member selected from the group consisting of tiotropium and derivatives thereof; the combination being therapeutically effective in the treatment of the diseases when administered by inhalation; as well as to a method of treating the obstructive airways and other inflammatory diseases comprising administering separately, simultaneously or sequentially to the mammal by inhalation a therapeutically effective amount of the combination of therapeutic agents; as well as to a pharmaceutical composition comprising a pharmaceutically acceptable carrier together with the combination of therapeutic agents; as well as to a product containing the compounds of the combination for separate, simultaneous or sequential administration by inhalation to a mammal for the treatment of obstructive airways and

Abstract: A compound of formula (I) wherein m, n, o, p, q, r, A, B, D, E, R1, R2,R3, R4, R5, R6, R7 and R8 are as defined in the description, useful in the treatment of respiratory, allergic, rheumatoid, body weight regulation, inflammatory and central nervous system disorders such as asthma, chronic obstructive pulmonary disease, adult respiratory diseases syndrome, shock, fibrosis, pulmonary hypersensitivity, allergic rhinitis, atopic dermatitis, psoriasis, weight control, rheumatoid arthritis, cachexia, crohn's disease, ulcerative colitis, arthritic conditions and other inflammatory diseases, depression, multi-infarct dementia and AIDS.

Abstract: The present invention relates to a method of treating or preventing emesis in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, azanorbornane derivatives and related compounds.